The new Fellows have been elected to the Academy in recognition of their exceptional contributions to the advancement of biomedical and health science, cutting edge research discoveries, and translating developments into benefits for patients and wider society.
This year Fellows were chosen from 365 candidates and will be formally admitted to the Academy at a ceremony on Wednesday 18 September 2024. Of the 58 Fellows, eight are from the University of Oxford and the new NDM Fellows are:
Professor Julian Knight FMedSci, Professor of Genomic Medicine and Deputy Director of the Centre for Human Genetics, Honorary Consultant Physician, Tutor and Fellow at Merton College, Director of the Medical Sciences Division Graduate School, Genomic Medicine Theme Lead at the NIHR Oxford Biomedical Research Centre and Research Director of the Central and South NHS Genomic Medicine Service Alliance. Prof Knight said: 'I am very grateful to the Academy and to all the brilliant researchers I have worked with over the years who have contributed to this recognition.'
Professor Jane McKeating FMedSci, Professor of Molecular Virology at the Nuffield Department of Medicine. Prof McKeating said: ‘I am delighted to be nominated and for our research to be recognised! A big thanks to current and ex-team members who have made scientific discovery a joy.’
Also elected was Professor Teresa Lambe OBE FMedSci, Calleva Head of Immunology at the Oxford Vaccine Group and Principal Investigator at the Pandemic Sciences Institute within NDM. Professor Lambe said: ‘It is a huge honour to be elected as a Fellow of the Academy of Medical Sciences. I have been fortunate to work with incredibly talented colleagues over the course of my career both in the UK and worldwide, and I’m incredibly proud that this work has been recognised.’
Professor Andrew Morris PMedSci, President of the Academy of Medical Sciences, said: ‘It is an honour to welcome these brilliant minds to our Fellowship. Our new Fellows lead pioneering work in biomedical research and are driving remarkable improvements in healthcare. We look forward to working with them, and learning from them, in our quest to foster an open and progressive research environment that improves the health of people everywhere through excellence in medical science.'